Concepts (120)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Phthalic Acids | 2 | 2024 | 13 | 0.940 |
Why?
|
| Maternal Exposure | 2 | 2024 | 152 | 0.850 |
Why?
|
| Tacrolimus | 2 | 2020 | 104 | 0.680 |
Why?
|
| Fetal Development | 4 | 2024 | 128 | 0.570 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2017 | 363 | 0.570 |
Why?
|
| Immunosuppressive Agents | 2 | 2020 | 658 | 0.530 |
Why?
|
| Mitochondria | 3 | 2015 | 761 | 0.450 |
Why?
|
| Drug Monitoring | 1 | 2018 | 285 | 0.440 |
Why?
|
| Brain Injuries, Traumatic | 3 | 2022 | 317 | 0.410 |
Why?
|
| Cognitive Dysfunction | 2 | 2025 | 338 | 0.260 |
Why?
|
| Stress Disorders, Post-Traumatic | 2 | 2025 | 677 | 0.250 |
Why?
|
| Fetal Weight | 2 | 2024 | 71 | 0.250 |
Why?
|
| Dopaminergic Neurons | 2 | 2017 | 61 | 0.240 |
Why?
|
| Biometry | 2 | 2024 | 102 | 0.220 |
Why?
|
| National Institute of Child Health and Human Development (U.S.) | 1 | 2024 | 9 | 0.220 |
Why?
|
| Parkinson Disease | 3 | 2017 | 723 | 0.210 |
Why?
|
| Pesticides | 1 | 2024 | 34 | 0.210 |
Why?
|
| Phenols | 1 | 2024 | 71 | 0.210 |
Why?
|
| Protein Kinases | 2 | 2017 | 317 | 0.210 |
Why?
|
| Benzhydryl Compounds | 1 | 2024 | 76 | 0.200 |
Why?
|
| Amyloid beta-Peptides | 1 | 2025 | 239 | 0.200 |
Why?
|
| Child Development | 2 | 2024 | 271 | 0.190 |
Why?
|
| Diffusion Tensor Imaging | 2 | 2022 | 259 | 0.190 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2024 | 230 | 0.180 |
Why?
|
| Repressor Proteins | 2 | 2017 | 772 | 0.180 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2024 | 999 | 0.170 |
Why?
|
| Area Under Curve | 2 | 2020 | 321 | 0.170 |
Why?
|
| Brain | 3 | 2025 | 3226 | 0.170 |
Why?
|
| Cesarean Section | 1 | 2024 | 435 | 0.160 |
Why?
|
| Birth Weight | 1 | 2022 | 343 | 0.160 |
Why?
|
| Drug Administration Schedule | 2 | 2020 | 731 | 0.160 |
Why?
|
| Tablets | 1 | 2018 | 37 | 0.140 |
Why?
|
| Biomarkers | 2 | 2025 | 3400 | 0.140 |
Why?
|
| Drug Compounding | 1 | 2018 | 40 | 0.140 |
Why?
|
| Pregnancy | 4 | 2024 | 7500 | 0.140 |
Why?
|
| Graft Rejection | 2 | 2020 | 558 | 0.130 |
Why?
|
| Logistic Models | 4 | 2024 | 1825 | 0.130 |
Why?
|
| Brain Injuries | 1 | 2022 | 709 | 0.130 |
Why?
|
| Prospective Studies | 3 | 2022 | 6495 | 0.120 |
Why?
|
| Kidney Transplantation | 2 | 2020 | 565 | 0.120 |
Why?
|
| Psychotic Disorders | 1 | 2017 | 154 | 0.110 |
Why?
|
| Neurons | 2 | 2015 | 2008 | 0.110 |
Why?
|
| Cell Death | 1 | 2015 | 235 | 0.110 |
Why?
|
| Oxygen Consumption | 1 | 2015 | 301 | 0.110 |
Why?
|
| Neuroimaging | 3 | 2022 | 400 | 0.110 |
Why?
|
| Green Fluorescent Proteins | 1 | 2015 | 367 | 0.110 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2014 | 64 | 0.100 |
Why?
|
| Dopamine | 1 | 2015 | 250 | 0.100 |
Why?
|
| Double-Blind Method | 1 | 2018 | 1625 | 0.100 |
Why?
|
| Male | 7 | 2025 | 64722 | 0.100 |
Why?
|
| Glycolysis | 1 | 2014 | 174 | 0.100 |
Why?
|
| Humans | 14 | 2025 | 130857 | 0.100 |
Why?
|
| Cell Line, Tumor | 2 | 2017 | 3705 | 0.090 |
Why?
|
| Cerebral Cortex | 1 | 2014 | 460 | 0.080 |
Why?
|
| Adult | 6 | 2024 | 31275 | 0.080 |
Why?
|
| Female | 7 | 2024 | 70681 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 2 | 2017 | 4709 | 0.080 |
Why?
|
| Gestational Age | 2 | 2024 | 1229 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 1 | 2014 | 1092 | 0.070 |
Why?
|
| Prognosis | 1 | 2018 | 4936 | 0.070 |
Why?
|
| Time Factors | 1 | 2018 | 6242 | 0.070 |
Why?
|
| Mice, Knockout | 1 | 2015 | 3839 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 2344 | 0.060 |
Why?
|
| Longitudinal Studies | 2 | 2024 | 1503 | 0.060 |
Why?
|
| Aged | 3 | 2025 | 20972 | 0.060 |
Why?
|
| Middle Aged | 3 | 2025 | 28513 | 0.050 |
Why?
|
| Term Birth | 1 | 2024 | 35 | 0.050 |
Why?
|
| Parity | 1 | 2024 | 84 | 0.050 |
Why?
|
| Mice | 3 | 2017 | 18245 | 0.050 |
Why?
|
| Young Adult | 3 | 2024 | 10025 | 0.050 |
Why?
|
| Positron-Emission Tomography | 1 | 2025 | 295 | 0.050 |
Why?
|
| Amniotic Fluid | 1 | 2024 | 149 | 0.050 |
Why?
|
| ROC Curve | 1 | 2024 | 617 | 0.050 |
Why?
|
| Animals | 4 | 2017 | 33937 | 0.050 |
Why?
|
| Anesthesia, Epidural | 1 | 2022 | 18 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2025 | 3877 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2024 | 8570 | 0.040 |
Why?
|
| Chronopharmacokinetics | 1 | 2020 | 1 | 0.040 |
Why?
|
| Biological Availability | 1 | 2020 | 140 | 0.040 |
Why?
|
| Body Weight | 1 | 2024 | 989 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2020 | 150 | 0.040 |
Why?
|
| Emotions | 1 | 2022 | 355 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2020 | 329 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2024 | 1685 | 0.030 |
Why?
|
| Brief Psychiatric Rating Scale | 1 | 2017 | 6 | 0.030 |
Why?
|
| Language Disorders | 1 | 2017 | 24 | 0.030 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2017 | 44 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2017 | 229 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2017 | 297 | 0.030 |
Why?
|
| Ubiquitin | 1 | 2017 | 132 | 0.030 |
Why?
|
| Ubiquitination | 1 | 2017 | 174 | 0.030 |
Why?
|
| Executive Function | 1 | 2017 | 128 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2022 | 2307 | 0.030 |
Why?
|
| Proteolysis | 1 | 2017 | 194 | 0.030 |
Why?
|
| RNA Interference | 1 | 2017 | 492 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2017 | 664 | 0.030 |
Why?
|
| Methylnitronitrosoguanidine | 1 | 2014 | 2 | 0.030 |
Why?
|
| Glucose-6-Phosphate | 1 | 2014 | 4 | 0.030 |
Why?
|
| Anxiety | 1 | 2021 | 1009 | 0.030 |
Why?
|
| Hexokinase | 1 | 2014 | 25 | 0.030 |
Why?
|
| NAD | 1 | 2014 | 50 | 0.030 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2014 | 35 | 0.030 |
Why?
|
| Acrylamides | 1 | 2014 | 27 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2017 | 961 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2017 | 1213 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2017 | 1571 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2014 | 586 | 0.020 |
Why?
|
| Cognition Disorders | 1 | 2017 | 559 | 0.020 |
Why?
|
| Piperidines | 1 | 2014 | 230 | 0.020 |
Why?
|
| Mitochondrial Diseases | 1 | 2014 | 150 | 0.020 |
Why?
|
| Dementia | 1 | 2017 | 430 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 2345 | 0.020 |
Why?
|
| Glucose | 1 | 2014 | 848 | 0.020 |
Why?
|
| Infant | 1 | 2024 | 13330 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2014 | 2907 | 0.020 |
Why?
|
| United States | 1 | 2024 | 11838 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2024 | 15016 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 6785 | 0.010 |
Why?
|
| Adolescent | 1 | 2024 | 20839 | 0.010 |
Why?
|
| Child | 1 | 2024 | 26223 | 0.010 |
Why?
|